Search for: "Ex parte Johnson & Johnson et al." Results 61 - 71 of 71
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2009, 1:00 am
(Managing Intellectual Property) (Law360) (Out-Law) ECJ rules German music distributor cannot sell two Bob Dylan compilation albums because Sony owns rights to songs in question: Sony Music Entertainment (Germany) GmbH v Falcon Neue Medien Vertrieb GmbH (IPKat) (Law360) ECJ: Date set for Advocate General’s opinion in L'Oréal SA, Lancôme parfums et beauté & Cie SNC, Laboratoire Garnier & Cie v Bellure NV, Malaika… [read post]
31 Jul 2008, 4:54 pm
Review Board of the Indiana Dept. of Workforce, et al. , an 8-page opinion, Sr. [read post]
13 Jun 2008, 3:40 am
, (IPKat), (IPKat), (Class 46), (IPKat), (IP Law360), Quanta – Supreme Court reverses CAFC decision in Quanta v LG Electronics; method patents exhaustible: (Peter Zura's 271 Patent Blog), (IP Updates), (Hal Wegner), (Patently-O), (Techdirt), (Patent Prospector), (Ars Technica), (Patent Docs), (Agricultural Law Blog), (Filewrapper), (Intellectual Property Law Blog), (Philip Brooks), (Philip Brooks guest blog), (IP ThinkTank), (Electronic Frontier Foundation), (IAM), (IAM), (IPBiz),… [read post]
2 May 2008, 7:00 am
: (IP ThinkTank), WIPO: T-Mobile, T-online domain names to be transferred to Deutsche Telekom: (Class 46), UK, Germany and US top Taylor Wessing’s first IP index: (Managing Intellectual Property) Global - Patents Leveraging IP to finance early-stage technology: (first part - IP finance), (second part – IP finance), WTO members support new disclosure requirements for patent applications relating to genetic resources and traditional knowledge:… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic choices:… [read post]